In chronic asthma mice model, we demonstrated that Epac had a protecting effect on airway remodeling, in that Epac activator 8pCPT inhibited, while Epac inhibitor ESI-09 promoted airway remodeling processes such as goblet cell hyperplasia, collagen deposition and ASMC hyperplasia. This evidence concerns the gene RAPGEF3 and chronic asthma.